相关实验视频

Updated: Jun 24, 2025

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

对非小细胞肺癌的术后免疫疗法的价值:一个池和元分析

Yanmeng Wu¹, Lin Hu¹, Shuling Zhang²

¹China Medical University, Shenyang, China.

Technology in cancer research & treatment

|June 14, 2024

概括

新辅助和辅助免疫疗法,特别是免疫检查点抑制剂 (ICI) 与化疗相结合,在可切除的非小细胞肺癌 (NSCLC) 中显示出显著的疗效. 与单独的化疗相比,术后免疫疗法可以改善生存结果和病理反应,而不会增加毒性.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
胸部外科手术胸部外科手术

背景情况:

非小细胞肺癌 (NSCLC) 仍然是全球癌症相关死亡的主要原因.
新辅助和辅助疗法对于改善切除性NSCLC的结果至关重要.
免疫检查点抑制剂 (ICI) 已成为各种癌症的有希望的治疗策略.

研究的目的:

在可切除非小细胞肺癌 (NSCLC) 患者中系统评估新辅助和辅助免疫疗法的疗效和安全性.
为了比较基于ICI的治疗方案与NSCLC的外科手术期间的传统化疗.

主要方法:

在主要数据库 (PubMed,Embase,Cochrane图书馆等) 进行全面的文献搜索. 在2024年2月16日之前.
包括随机对照试验 (RCT) 和单臂试验,评估基于ICI的新辅助和/或辅助疗法.
使用Stata (16.0) 软件进行数据提取和统计分析.

主要成果:

与化疗相结合的新辅助性ICI显著改善了可切除NSCLC的病理完整反应,主要病理反应,整体存活率 (OS) 和无事件存活率 (EFS),与单独的化疗相比.
与辅助化疗相比,辅助ICI治疗与疾病进展或死亡风险降低有关.
术后免疫疗法与化疗相结合时,表现出与单独化疗相比的可比性安全性,但毒性没有增加.

结论:

术后免疫疗法是可切除NSCLC患者的安全和有效的治疗策略.
在外科手术期间将ICI与化疗相结合,可以提高病理反应和生存结果 (EFS/DFS/OS),而不会影响安全.
这些发现支持将免疫疗法纳入可切除NSCLC的标准外科治疗.

关键词:

辅助疗法是一种辅助疗法.免疫疗法免疫疗法新辅助疗法是一种新辅助疗法.非小细胞肺癌的肺癌.

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.